Skip to content
Subscriber Only

Regeneron Seeks FDA Emergency Clearance for Covid-19 Therapy

  • Antibody cocktail showed promise in early-stage clinical trial
  • Trump was given Regeneron therapy for coronavirus last week
Regeneron Pharmaceuticals Inc headquarters in Tarrytown, N.Y., U.S., on June 12.

Regeneron Pharmaceuticals Inc headquarters in Tarrytown, N.Y., U.S., on June 12.

Photographer: Michael Nagle/Bloomberg
Updated on

Regeneron Pharmaceuticals Inc. said it has asked federal regulators to authorize its antibody treatment for Covid-19 for emergency use.

President Donald Trump received the antibody cocktail last Friday under a compassionate use program after becoming sick with the coronavirus. Trump hailed Regeneron’s treatment in a video posted on Twitter Wednesday, saying he would authorize its emergency use and make it available to Americans for free.